Showing results (11-20 of 400) with videos related to

Sort By:
Pageof 40
American Journal of Clinical Oncology|March 26, 2015
Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of published trialsFausto Petrelli, Andrea Coinu, Mara Ghilardi, et al.
Breast Cancer Research and Treatment|July 18, 2013
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
European Urology|July 16, 2013
Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysisFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2013
Platinum rechallenge in patients with advanced NSCLC: a pooled analysisFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Anti-Cancer Drugs|April 9, 2016
Neoadjuvant dose-dense chemotherapy for locally advanced breast cancer: a meta-analysis of published studiesFausto Petrelli, Andrea Coinu, Veronica Lonati, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2015
Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studiesFausto Petrelli, Mary Cabiddu, Andrea Coinu, et al.
Clinical Genitourinary Cancer|May 12, 2015
Surveillance or Adjuvant Treatment With Chemotherapy or Radiotherapy in Stage I Seminoma: A Systematic Review and Meta-Analysis of 13 StudiesFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patientsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Medicine|July 2, 2016
Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Clinical Genitourinary Cancer|December 4, 2014
Enzalutamide after docetaxel and abiraterone acetate treatment in prostate cancer: a pooled analysis of 10 case seriesFausto Petrelli, Andrea Coinu, Karen Borgonovo, et al.
Pageof 40